Impel plans $75M IPO to bring nasal migraine drug to market
12th April 2021 Uncategorised 0 Impel plans $75M IPO to bring nasal migraine drug to market
ntaylor
Mon, 04/12/2021 – 11:36
More: Impel plans M IPO to bring nasal migraine drug to market
Source: fierce